Literature DB >> 19249087

A PP2A regulatory subunit regulates C. elegans insulin/IGF-1 signaling by modulating AKT-1 phosphorylation.

Srivatsan Padmanabhan1, Arnab Mukhopadhyay, Sri Devi Narasimhan, Gregory Tesz, Michael P Czech, Heidi A Tissenbaum.   

Abstract

The C. elegans insulin/IGF-1 signaling (IIS) cascade plays a central role in regulating life span, dauer, metabolism, and stress. The major regulatory control of IIS is through phosphorylation of its components by serine/threonine-specific protein kinases. An RNAi screen for serine/threonine protein phosphatases that counterbalance the effect of the kinases in the IIS pathway identified pptr-1, a B56 regulatory subunit of the PP2A holoenzyme. Modulation of pptr-1 affects IIS pathway-associated phenotypes including life span, dauer, stress resistance, and fat storage. We show that PPTR-1 functions by regulating worm AKT-1 phosphorylation at Thr 350. With striking conservation, mammalian B56beta regulates Akt phosphorylation at Thr 308 in 3T3-L1 adipocytes. In C. elegans, this ultimately leads to changes in subcellular localization and transcriptional activity of the forkhead transcription factor DAF-16. This study reveals a conserved role for the B56 regulatory subunit in regulating insulin signaling through AKT dephosphorylation, thereby having widespread implications in cancer and diabetes research.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19249087      PMCID: PMC2707143          DOI: 10.1016/j.cell.2009.01.025

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  79 in total

1.  Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes.

Authors:  Satoshi Ugi; Takeshi Imamura; Hiroshi Maegawa; Katsuya Egawa; Takeshi Yoshizaki; Kun Shi; Toshiyuki Obata; Yousuke Ebina; Atsunori Kashiwagi; Jerrold M Olefsky
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

2.  Genetic analysis of chemosensory control of dauer formation in Caenorhabditis elegans.

Authors:  J J Vowels; J H Thomas
Journal:  Genetics       Date:  1992-01       Impact factor: 4.562

3.  Genes that regulate both development and longevity in Caenorhabditis elegans.

Authors:  P L Larsen; P S Albert; D L Riddle
Journal:  Genetics       Date:  1995-04       Impact factor: 4.562

4.  A C. elegans mutant that lives twice as long as wild type.

Authors:  C Kenyon; J Chang; E Gensch; A Rudner; R Tabtiang
Journal:  Nature       Date:  1993-12-02       Impact factor: 49.962

5.  Specification of male development in Caenorhabditis elegans: the fem genes.

Authors:  J Kimble; L Edgar; D Hirsh
Journal:  Dev Biol       Date:  1984-09       Impact factor: 3.582

6.  Interacting genes in nematode dauer larva formation.

Authors:  D L Riddle; M M Swanson; P S Albert
Journal:  Nature       Date:  1981-04-23       Impact factor: 49.962

7.  DAF-5 is a Ski oncoprotein homolog that functions in a neuronal TGF beta pathway to regulate C. elegans dauer development.

Authors:  Li S da Graca; Karen K Zimmerman; Melissa C Mitchell; Marianne Kozhan-Gorodetska; Kamila Sekiewicz; Yairani Morales; Garth I Patterson
Journal:  Development       Date:  2003-12-17       Impact factor: 6.868

Review 8.  Regulated membrane trafficking of the insulin-responsive glucose transporter 4 in adipocytes.

Authors:  Robert T Watson; Makoto Kanzaki; Jeffrey E Pessin
Journal:  Endocr Rev       Date:  2004-04       Impact factor: 19.871

9.  Regulation of protein phosphatase 1 and 2A activities by insulin during myogenesis in rat skeletal muscle cells in culture.

Authors:  M Srinivasan; N Begum
Journal:  J Biol Chem       Date:  1994-04-29       Impact factor: 5.157

10.  C. elegans SGK-1 is the critical component in the Akt/PKB kinase complex to control stress response and life span.

Authors:  Maren Hertweck; Christine Göbel; Ralf Baumeister
Journal:  Dev Cell       Date:  2004-04       Impact factor: 12.270

View more
  91 in total

1.  Antipsychotic drugs activate the C. elegans akt pathway via the DAF-2 insulin/IGF-1 receptor.

Authors:  Kathrine R Weeks; Donard S Dwyer; Eric J Aamodt
Journal:  ACS Chem Neurosci       Date:  2010-03-25       Impact factor: 4.418

2.  PDK1 recruitment to the SHPS-1 signaling complex enhances insulin-like growth factor-i-stimulated AKT activation and vascular smooth muscle cell survival.

Authors:  Xinchun Shen; Gang Xi; Yashwanth Radhakrishnan; David R Clemmons
Journal:  J Biol Chem       Date:  2010-07-19       Impact factor: 5.157

3.  Insulin-like growth factor-binding protein-2 is required for osteoclast differentiation.

Authors:  Victoria E DeMambro; Laura Maile; Christine Wai; Masanobu Kawai; Teresa Cascella; Clifford J Rosen; David Clemmons
Journal:  J Bone Miner Res       Date:  2012-02       Impact factor: 6.741

Review 4.  Starvation Responses Throughout the Caenorhabditis elegans Life Cycle.

Authors:  L Ryan Baugh; Patrick J Hu
Journal:  Genetics       Date:  2020-12       Impact factor: 4.562

Review 5.  Novel Ser/Thr protein phosphatases in cell death regulation.

Authors:  Haipeng Sun; Yibin Wang
Journal:  Physiology (Bethesda)       Date:  2012-02

Review 6.  The impact of phosphatases on proliferative and survival signaling in cancer.

Authors:  Goutham Narla; Jaya Sangodkar; Christopher B Ryder
Journal:  Cell Mol Life Sci       Date:  2018-05-03       Impact factor: 9.261

7.  Fine-tuning AKT kinase activity through direct lysine methylation.

Authors:  Jianping Guo; Wenyi Wei
Journal:  Cell Cycle       Date:  2019-05-03       Impact factor: 4.534

Review 8.  AKT/PKB Signaling: Navigating the Network.

Authors:  Brendan D Manning; Alex Toker
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

9.  InAKTivation of insulin/IGF-1 signaling by dephosphorylation.

Authors:  Sri Devi Narasimhan; Arnab Mukhopadhyay; Heidi A Tissenbaum
Journal:  Cell Cycle       Date:  2009-12       Impact factor: 4.534

Review 10.  An overview of stress response and hypometabolic strategies in Caenorhabditis elegans: conserved and contrasting signals with the mammalian system.

Authors:  Benjamin Lant; Kenneth B Storey
Journal:  Int J Biol Sci       Date:  2010-01-07       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.